PM2.5 aggravates airway inflammation in asthmatic mice: activating NF-κB via MyD88 signaling pathway

Lei Wang1, Yanzhi Cui1, Hu Liu1

  • 1Department of Respiratory Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, Shanxi, China.

Insights

Particulate Matter 2.5 (PM2.5) exposure exacerbates allergic lung inflammation in asthma models by activating the TLR2/TLR4/MyD88 pathway. This pathway

Area of Science:

  • Environmental Health
  • Immunology
  • Respiratory Medicine

Background:

  • The precise role of Particulate Matter 2.5 (PM2.5) in bronchial asthma pathogenesis is not fully understood.
  • PM2.5 contains microelements like lipopolysaccharide, potentially contributing to asthma incidence.

Purpose of the Study:

  • To investigate the impact of PM2.5 on allergic lung inflammation in a mouse model of asthma.
  • To elucidate the involvement of Toll-like receptor (TLR) signaling pathways in PM2.5-induced asthma exacerbation.

Main Methods:

  • Asthma models were established in wild-type (WT) and deficient mice lacking Toll-like receptor 4 (TLR4-/-), Toll-like receptor 2 (TLR2-/-), and Myeloid differentiation primary response 88 (MyD88-/-).
  • The effects of PM2.5 exposure on inflammatory cell counts, cytokine expression (IL-12, KC, Eotaxin, IL-5, IL-13, MCP-3), and immunoglobulin levels (OVA specific IgE, IgG1) were assessed.

Main Results:

  • PM2.5 exposure increased inflammatory cells (macrophages, neutrophils) and upregulated IL-12 and KC expression in WT mice.
  • These inflammatory markers were downregulated in TLR2-/-, TLR4-/-, and MyD88-/- mice, indicating a role for these receptors.
  • PM2.5 exposure, particularly in combination with Ovalbumin (OVA), led to increased neutrophil counts, elevated levels of specific cytokines and chemokines, and heightened OVA-specific IgE and IgG1 in WT mice.

Conclusions:

  • PM2.5 may aggravate allergic lung inflammation in asthmatic mice by activating the NF-κB pathway via the TLR2/TLR4/MyD88 signaling cascade.
  • Microelements within PM2.5, such as lipopolysaccharide, are implicated as significant factors in the high prevalence of asthma.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
793
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.2K
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
561